Principal Investigator
MATHILDE HUNAULT
University Hospital, Angers
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 11
Trial Status
Recruiting1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
PrincipalinvestigatorStart date: 2025-02-06
Research Network
Collaboration Network
2 collaborators·1 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
University Hospital, Angers
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
1 similar investigators found
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
All 1 trials loaded